Boston Scientific Launches Precision Spectra™ Spinal Cord Stimulator System In The United States

Boston Scientific Corporation has received U.S. FDA approval for its Precision Spectra Spinal Cord Stimulator System. The company is now beginning a limited launch of what it says is the world’s first and only SCS system with Illumina 3D™ software and 32 contacts.

Boston Scientific Precision Spectra SystemBoston Scientific Launches Precision Spectra™ Spinal Cord Stimulator System In The United States (via PR Newswire)

World’s First and Only System with Illumina 3D™ Software and 32 Contacts is Designed to Provide Pain Relief to a Broad Spectrum of Chronic Pain Patients NATICK, Mass., April 12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration…

published: April 15, 2013 in: Approval/Clearance, Boston Scientific, Launches / Withdrawals, Pain management

Most read

Latest

^